Creatinine Test Market Opportunities, Trends, Applications, And Growth Forecast To 2029 Creatinine is a residual chemical substance left from energy-producing substances in the human body. High creatinine levels are harmful to the human body, especially to the kidney. The symptoms of elevated creatinine levels typically account for weakness, tiredness, fatigue, dehydration, and chaotic behaviour. However, in most cases, there are no visible symptoms of high creatinine levels. A routine blood test might reveal an excess of creatinine in body. The urine test, creatinine clearance test, and serum creatinine test are three tests done to discover level creatinine in the blood. To this end, government have been taking relevant initiatives and promoting R&D efforts. In addition to these factors, growing prevalence of kidney disorders are facilitating the growth of the global creatinine test market. For More Industry Insights Read: https://www.fairfieldmarketresearch.com/report/creatinine-test-market Rising Prevalence of Renal Disorders to Steepen Growth Curve of Creatinine Test Market Recent years have witnessed an incessant rise in renal disorders. One of the major causes of these disorders is diabetes. Diabetes can damage blood arteries in the kidney as well as nephrons, resulting in kidney damage. The patients affected with kidney disorders require consistent monitoring of creatinine & albumin with respect to their ratios in urine. Therefore, many urine analysis techniques and modern products are being deployed to measure the level of chemical compounds such as creatinine, ketones, and glucose in the urine. Henceforth, the growing incidence of renal disorders and diabetes is likely to drive the creatinine test market to maturity in the coming years. Surge in Urinary Tract Obstruction to Sustain Demand for Creatinine Test Urinary tract obstruction is majorly caused due to kidney stones. The growing occurrence of kidney stones can be attributed to the changing lifestyle of individuals. Noticeably, the prevalence of urinary tract obstruction is likely to grow with the rising cases of kidney stones. Furthermore, the soaring incidence of cancer and pervasiveness of postoperative infection in kidney transplant recipients and rise in individuals suffering from hydronephrosis is fuelling the sector’s growth. Then, the increasing number of catheter and stent manufacturers coupled with distributors for urinary tract obstruction has resulted in sufficient availability of goods. This in turn is expected to boost the growth of the creatinine test market in the years to come.